Insider Transactions in Q4 2025 at Kymera Therapeutics, Inc. (KYMR)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2025
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-2.18%
|
$2,340,000
$78.23 P/Share
|
|
Dec 31
2025
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.15%
|
$60,000
$2.08 P/Share
|
|
Dec 17
2025
|
Pamela Esposito |
SELL
Open market or private sale
|
Direct |
27,563
-73.49%
|
$2,260,166
$82.85 P/Share
|
|
Dec 17
2025
|
Pamela Esposito |
BUY
Exercise of conversion of derivative security
|
Direct |
27,563
+30.88%
|
$964,705
$35.99 P/Share
|
|
Dec 17
2025
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,595
+0.39%
|
$98,610
$38.53 P/Share
|
|
Dec 12
2025
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect |
678
-0.02%
|
$61,698
$91.04 P/Share
|
|
Dec 11
2025
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect |
6,101
-0.14%
|
$555,191
$91.23 P/Share
|
|
Dec 11
2025
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
2,005,813
+19.01%
|
$172,499,918
$86.0 P/Share
|
|
Dec 10
2025
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect |
229,809
-0.99%
|
$20,682,810
$90.73 P/Share
|
|
Dec 08
2025
|
Jared Gollob Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
49,307
-5.9%
|
$4,388,323
$89.77 P/Share
|
|
Dec 08
2025
|
Jared Gollob Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
49,307
+23.64%
|
$246,535
$5.33 P/Share
|
|
Dec 08
2025
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-13.15%
|
$8,900,000
$89.17 P/Share
|
|
Dec 08
2025
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+11.62%
|
$200,000
$2.08 P/Share
|
|
Dec 08
2025
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,000
-77.48%
|
$445,000
$89.81 P/Share
|
|
Dec 08
2025
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$70,000
$14.18 P/Share
|
|
Oct 29
2025
|
Nello Mainolfi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-1.46%
|
$1,800,000
$60.73 P/Share
|
|
Oct 29
2025
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.16%
|
$60,000
$2.08 P/Share
|
|
Oct 15
2025
|
Jared Gollob Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
59,576
-10.13%
|
$3,634,136
$61.92 P/Share
|
|
Oct 15
2025
|
Jared Gollob Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
51,209
+14.01%
|
$51,209
$1.7 P/Share
|
|
Oct 13
2025
|
Jared Gollob Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,114
-2.56%
|
$186,840
$60.0 P/Share
|
|
Oct 13
2025
|
Jared Gollob Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,473
+0.6%
|
$1,473
$1.7 P/Share
|
|
Oct 13
2025
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$295,000
$59.19 P/Share
|
|
Oct 13
2025
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$50,000
$10.34 P/Share
|